|
Sign In to gain access to subscriptions and/or personal tools.
|
Muscarinic effects and foetal cardiovascular and hormonal responses in utero
Jianli Zheng
Perinatal Biology Centre, Soochow University School of Medicine, Suzhou 215123, People's Republic of China
Weili Yang
Perinatal Biology Centre, Soochow University School of Medicine, Suzhou 215123, People's Republic of China
Li Cao
Perinatal Biology Centre, Soochow University School of Medicine, Suzhou 215123, People's Republic of China
Shigang Li
Perinatal Biology Centre, Soochow University School of Medicine, Suzhou 215123, People's Republic of China
Yuying Zhang
Perinatal Biology Centre, Soochow University School of Medicine, Suzhou 215123, People's Republic of China
Zhen Wan
Perinatal Biology Centre, Soochow University School of Medicine, Suzhou 215123, People's Republic of China
Caiping Mao
Perinatal Biology Centre, Soochow University School of Medicine, Suzhou 215123, People's Republic of China, maocaiping{at}suda.edu.cn
Introduction. Cholinergic mechanisms play an important role in the control of hormonal and vascular regulation. However, in utero development of cholinergic regulation in the foetal hormonal systems is not clearly understood.This study investigated foetal hormonal and cardiovascular responses following application of the muscarinic antagonist atropine.
Materials and methods. Chronically prepared near-term ovine foetuses (control and experimental: n=5, each group) were used.After 4—5 days surgical recovery, conscious ewes and their foetuses were tested in vivo.
Results. In response to intravenous atropine, foetal systolic, diastolic, and mean arterial pressure, as well as heart rate, increased immediately. Inhibition of muscarinic systems in the circulation caused a reduction of plasma angiotensin II levels, while angiotensin I in the circulation remained unchanged in the foetus. In addition, foetal plasma aldosterone levels were significantly increased following blockade of the cholinergic receptor, while other hormones, including arginine vasopressin, adrenocorticotrophic hormone, and atrial natriuretic peptide, were not changed in foetal blood under the same condition.
Conclusions. The results suggest that foetal automatic systems, not those hormonal factors tested, play a major role in cholinergic mechanisms mediating cardiovascular control. Furthermore, the data provide new information on how muscarinic inhibition affects renin-angiotensin system and adrenal cortex functions. Key words: aldosterone, angiotensin-converting enzyme, autonomic regulation, foetus
Key Words: aldosterone angiotensin-converting enzyme autonomic regulation foetus
References
- Slotkin TA Fetal nicotine or cocaine exposure: which one is worse? Pharmacol Exp Ther 1998;285:931-45.[Abstract/Free Full Text]
- Yuan H., Platt RW, Morin L., Joseph KS, Kramer MS Fetal deaths in the United States, 1997 vs 1991. Am J Obstet Gynecol 2005;193:489-95.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zdravkovic T., Genbacev O., McMaster MT, Fisher SJ The adverse effects of maternal smoking on the human placenta: a review. Placenta 2005;26(suppl A):S81-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Lee SB, Kim SY, Sung KW Cardiovascular regulation by cholinergic mechanisms in rostral ventrolateral medulla of spontaneously hypertensive rats. Eur J Pharmacol 1991;205:117-23.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Sommers DK, Meyer EC, van Wyk M. The effect of neostigmine on metoclopramide-induced aldosterone secretion after the administration of muscarinic antagonists in man. Eur J Clin Pharmacol 1990;38:401-03.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Jánossy A., Orsó E., Szalay KS et al. Cholinergic regulation of the rat adrenal zona glomerulosa. J Endocrinol 1998;157:305-15.[Abstract]
- Poller U., Nedelka G., Radke J., Pönicke K., Brodde OE Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol 1997;29:187-93.[Abstract]
- Lindh B., Hokfelt T. Structural and functional aspects of acetylcholine peptide coexistence in the autonomic nervous system. Prog Brain Res 1990;84:175-91.[Web of Science][Medline]
[Order article via Infotrieve]
- De Groat WC, Booth AM Inhibition and facilitation in parasympathetic ganglia of the urinary bladder. Fed Proc 1980;39:2990-6.[Web of Science][Medline]
[Order article via Infotrieve]
- Iwasaki K., Zhang R., Zuckerman JH, Levine BD Dose-response relationship of the cardiovascular adaptation to endurance training in healthy adults: how much training for what benefit? J Appl Physiol 2003;95:1575-83.[Abstract/Free Full Text]
- Galanter CA, Wasserman G., Sloan RP, Pine DS Changes in autonomic regulation with age: implications for psychopharmacologic treatments in children and adolescents. J Child Adolesc Psychopharmacol 1999; 9:257-65.[Web of Science][Medline]
[Order article via Infotrieve]
- Terzolo M., Matrella C., Boccuzzi A. et al. Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features. J Endocrinol Invest 1999;22:48-54.[Web of Science][Medline]
[Order article via Infotrieve]
- O
wiecimska J., Ziora K., Adamczyk P. et al. Effects of neuroendocrine changes on results of ambulatory blood pressure monitoring (ABPM) in adolescent girls with anorexia nervosa. Neuro Endocrinol Lett 2007;28:410-16.[Medline]
[Order article via Infotrieve] - Rademaker MT, Charles CJ, Espiner EA et al. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Coll Cardiol 2002;40:1495-505.[Abstract/Free Full Text]
- Shi L., Yao J., Koos BJ, Xu Z. Induced fetal depressor or pressor responses associated with c-fos by intravenous or intracerebroventricular losartan. Dev Brain Res 2004; 153:53-60.[CrossRef][Medline]
[Order article via Infotrieve]
- Xu Z., Glenda C., Day L., Yao J., Ross MG Central angiotensin induction of fetal brain c-fos expression and swallowing activity. Am J Physiol Regul Integr Comp Physiol 2001; 280:R1837-43.[Abstract/Free Full Text]
- Xu Z., Nijland MJ, Ross MG Plasma osmolality dipsogenic thresholds and c-fos expression in the near-term ovine fetus. Pediatr Res 2001;49:678-85.[Web of Science][Medline]
[Order article via Infotrieve]
- Naguib M., Gomaa M. Atropine-neostigmine mixture: a dose-response study. Can J Anaesth 1989;6:412-17.
- Brezenoff HE, Giuliano R. Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu Rev Pharmacol Toxicol 1982;22:341-81.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Barbosa SP, de Gobbi JI, Zilioli L. et al. Role of cholinergic and adrenergic pathways of the medial septal area in the water intake and pressor response to central angiotensin II and carbachol in rats. Brain Res Bull 1995;37:463-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Harding JW, Jensen LL, Quirk WS, Dewey AL, Wright JW Brain angiotensin: critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function. Peptides 1989;10:261-4.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Breen S., Rees S., Walker D. Identification of brainstem neurons responding to hypoxia in fetal and newborn sheep. Brain Res 1997;748:107-21.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ali-Melkkila T., Kanto J., Iisalo E. Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anaesthesiol Scand 1993;37:633-42.[Web of Science][Medline]
[Order article via Infotrieve]
- Lazartigues E., Brefel-Courbon C., Tran MA, Montastruc JL, Rascol O. Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanisms. Br J Pharmacol 1999;127:1657-65.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Saito R., Kamiya HO, Ono N. Role of the central muscarinic receptor of prostaglandin I2 in cardiovascular function in rat. Brain Res 1985;330:167-9.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kinney HC, ODonnell TJ, Kriger P., White WF Early developmental changes in [3H]nicotine binding in the human brainstem. Neuroscience 1993;55:1127-38.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kinney HC, Panigrahy A., Rava LA, White WF Three-dimensional distribution of [3H]quinuclidinyl benzilate binding to muscarinic cholinergic receptors in the developing human brainstem. J Comp Neurol 1995;362:350-67.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Volpe M., Musumeci B., De Paolis P., Savoia C., Morganti A. Angiotensin II AT2 receptor subtype: an uprising frontier in cardiovascular disease? J Hypertens 2003;21:1429-43.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Pratt RE Angiotensin II and the control of cardiovascular structure. J Am Soc Nephrol 1999;10(suppl 11):120-8.
- Riegger GA, Albert M., Kochsiek K. Cardiovascular effects of AVP and ANG in experimental pulmonic stenosis in rats. Am J Physiol 1988;254:H438-42.[Web of Science][Medline]
[Order article via Infotrieve]
- Reid IA Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992;262:E763-78.[Web of Science][Medline]
[Order article via Infotrieve]
- Guillery EN, Robillard JE The renin-angiotensin system and blood pressure regulation during infancy and childhood. Pediatr Clin North Am 1993; 40:61-79.[Web of Science][Medline]
[Order article via Infotrieve]
- Hall JE The renin-angiotensin system: renal actions and blood pressure regulation. Compr Ther 1991;17:8-17.[Medline]
[Order article via Infotrieve]
- Mitsui T., Nomura S., Itakura A., Mizutani S. Role of aminopeptidases in the blood pressure regulation. Biol Pharm Bull 2004;27:768-71.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Scott BB, McGeehan GM, Harrison RK Development of inhibitors of the aspartyl protease renin for the treatment of hypertension. Curr Protein Pept Sci 2006; 7:241-54.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ondetti MA, Rubin B., Cushman DW Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 1977; 196:441-4.[Abstract/Free Full Text]
- Young MJ, Funder JW Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system. J Hypertens 2002;20:1465-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Fuller PJ Aldosterone and its mechanism of action: more questions than answers. Aust N Z J Med 1995; 25:800-07.[Web of Science][Medline]
[Order article via Infotrieve]
- Johnston CI, Hodsman PG, Kohzuki M., Casley DJ, Fabris B., Phillips PA Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists. Am J Med 1989;87:24S-28S.[Medline]
[Order article via Infotrieve]
This version was published on September
1, 2009
Journal of Renin-Angiotensin-Aldosterone System, Vol. 10, No. 3,
138-146 (2009)
DOI: 10.1177/1470320309104866

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|